Gartisertib (VX-803) is an orally active and selective Rad3-related protein (ATR) inhibitor with antitumor activity, inhibiting the antiproliferative effect induced in ccRCC cells, and inhibiting ATR-driven phosphorylation of checkpoint kinase 1 (Chk1), useful for studying solid tumors.
Molecular Weight:
541.55
Purity:
99.52%
CAS Number:
[1613191-99-3]
Formula:
C25H29F2N9O3
Target:
ATM/ATR
T10407
T10407
* VAT and and shipping costs not included. Errors and price changes excepted